Deficiency of coagulation factors is associated with the bleeding diathesis of severe yellow fever
- PMID: 37226021
- DOI: 10.1007/s00277-023-05262-x
Deficiency of coagulation factors is associated with the bleeding diathesis of severe yellow fever
Abstract
Yellow fever (YF) is an acute tropical infectious disease caused by an arbovirus and can manifest as a classic hemorrhagic fever. The mechanism of the bleeding diathesis in YF is not well understood. We assessed clinical and laboratory data (including a panel of coagulation tests) from 46 patients with moderate (M) and severe (S) YF admitted to a local hospital between January 2018 and April 2018. Among 46 patients, 34 had SYF of whom 12 (35%) patients died. A total of 21 (45%) patients developed some type of bleeding manifestation and 15 (32%) presented severe bleeding. Patients with SYF had more severe thrombocytopenia (p = 0.001); prolonged activated partial thromboplastin time (aPTT) and thrombin time (TT) (p = 0.03 and p = 0.005, respectively); reduced plasma levels of coagulation factor (F) II (p < 0.01), FIX (p = 0.01), and FX (p = 0.04); and D-dimer levels almost 10 times higher (p < 0.01) when compared with patients with MYF. Patients who died had more bleeding (p = 0.03), more major bleeding (p = 0.03), prolonged international normalized ratio (INR) and aPTT (p = 0.003 and p = 0.002, respectively), as well as lower activity of FII (p = 0.02), FV (p = 0.001), FVII (p = 0.005), FIX (p = 0.01), and protein C (p = 0.01) than the ones who survived. FVIII levels were either normal or increased in all patients studied. Our results suggest that the bleeding diathesis of SYF is associated with the deficiency of coagulation factors produced by the liver. Prolonged INR and aPTT and reduced FII, FV, FVII, FIX, and protein C were associated with death.
Keywords: Bleeding; Coagulation; Coagulation factor; Hemostasis; Yellow fever.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
[A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].Ther Umsch. 1999 Sep;56(9):509-12. doi: 10.1024/0040-5930.56.9.509. Ther Umsch. 1999. PMID: 10517121 German.
-
Coagulation Testing in the Core Laboratory.Lab Med. 2017 Nov 8;48(4):295-313. doi: 10.1093/labmed/lmx050. Lab Med. 2017. PMID: 29126301 Review.
-
Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.Thromb Res. 2013 Jul;132(1):e70-5. doi: 10.1016/j.thromres.2013.05.015. Epub 2013 Jun 13. Thromb Res. 2013. PMID: 23769659
-
Coagulation factors and inhibitors in thawed plasma stored at 1-6 °C for 5 days in China.Transfus Apher Sci. 2014 Apr;50(2):274-80. doi: 10.1016/j.transci.2014.01.002. Epub 2014 Jan 10. Transfus Apher Sci. 2014. PMID: 24472665 Clinical Trial.
-
Congenital combined defects of factor VII: a critical review.Acta Haematol. 2007;117(1):51-6. doi: 10.1159/000096789. Epub 2006 Nov 8. Acta Haematol. 2007. PMID: 17095860 Review.
Cited by
-
Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.Biofabrication. 2024 Jun 5;16(3):032008. doi: 10.1088/1758-5090/ad4c0b. Biofabrication. 2024. PMID: 38749416 Free PMC article. Review.
-
Pathogenesis and clinical management of arboviral diseases.World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489. World J Virol. 2025. PMID: 40134841 Free PMC article. Review.
-
Hypocoagulability in severe yellow fever infection is associated with bleeding: results from a cohort study.Res Pract Thromb Haemost. 2024 Apr 26;8(4):102427. doi: 10.1016/j.rpth.2024.102427. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38817949 Free PMC article.
-
Colombian consensus on the care of critically ill patients with suspected or confirmed severe yellow fever.Lancet Reg Health Am. 2025 Jun 11;48:101144. doi: 10.1016/j.lana.2025.101144. eCollection 2025 Aug. Lancet Reg Health Am. 2025. PMID: 40585555 Free PMC article. Review.
References
-
- Erickson K, Pfeiffer K (2015) Spectrum of disease outcomes in mice infected with YFV-17D. J Gen Virol Microbiol Soc 1328:1339
-
- Ellis R, Barrett T (2008) The enigma of yellow fever in East Africa. Reviews In Medical Virology. Wiley 331:346
-
- Brazil. Ministry of Health.Health Surveillance Department. Department of Immunization and Communicable Diseases. Manual for the clinical management of yellow fever [electronic resource]/Ministry of Health, Department of Surveillance in Health, Department of Immunization and Communicable Diseases – Brasília: Ministry of Health, 2019
-
- Figueiredo M (2006) Viral hemorrhagic fevers in Brazil. J Brazil Soc Trop Med FapUNIFESP (SciELO) 203:210
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous